X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (14) 14
humans (13) 13
oncology (13) 13
female (11) 11
aged (8) 8
middle aged (8) 8
beer (7) 7
biochemistry (7) 7
chemistry (7) 7
compositions or test papers therefor (7) 7
condition-responsive control in microbiological orenzymological processes (7) 7
enzymology (7) 7
male (7) 7
measuring or testing processes involving enzymes, nucleicacids or microorganisms (7) 7
metallurgy (7) 7
microbiology (7) 7
mutation (7) 7
mutation or genetic engineering (7) 7
processes of preparing such compositions (7) 7
spirits (7) 7
vinegar (7) 7
wine (7) 7
adult (6) 6
aged, 80 and over (6) 6
physics (6) 6
combinatorial chemistry (5) 5
crizotinib (5) 5
immunotherapy (5) 5
investigating or analysing materials by determining theirchemical or physical properties (5) 5
libraries, e.g. chemical libraries, in silicolibraries (5) 5
measuring (5) 5
mutations (5) 5
testing (5) 5
comprehensive genomic profiling (4) 4
gene expression profiling (4) 4
genomics (4) 4
lung neoplasms - genetics (4) 4
melanoma (4) 4
targeted therapy (4) 4
alk (3) 3
cancer (3) 3
cell lung-cancer (3) 3
exons (3) 3
lung neoplasms - drug therapy (3) 3
medicine (3) 3
neoplasms - genetics (3) 3
protein kinase inhibitors - therapeutic use (3) 3
resistance (3) 3
sensitivity (3) 3
adenocarcinoma (2) 2
adolescent (2) 2
alk fusions (2) 2
alternative splicing (2) 2
amplification (2) 2
antineoplastic agents - therapeutic use (2) 2
article (2) 2
c-met (2) 2
calculating (2) 2
cancer genomics (2) 2
carcinoma, non-small-cell lung - drug therapy (2) 2
carcinoma, non-small-cell lung - genetics (2) 2
chemotherapy (2) 2
child (2) 2
clinical sequencing (2) 2
cluster analysis (2) 2
computing (2) 2
counting (2) 2
ctla-4 blockade (2) 2
disease-free survival (2) 2
dna mutational analysis (2) 2
dna repair - genetics (2) 2
electric digital data processing (2) 2
expression (2) 2
gene expression regulation, neoplastic - drug effects (2) 2
genetics (2) 2
genomic profiling (2) 2
genomics - methods (2) 2
glioma (2) 2
hematology (2) 2
high-throughput nucleotide sequencing (2) 2
inflammatory myofibroblastic tumor (2) 2
information and communication technology [ict] specially adaptedfor specific application fields (2) 2
inhibition (2) 2
juxtamembrane domain (2) 2
lung cancer (2) 2
mismatch repair (2) 2
mutation - genetics (2) 2
neoplasm metastasis (2) 2
neoplasm staging (2) 2
neoplasms (2) 2
neoplasms - drug therapy (2) 2
neoplasms - metabolism (2) 2
oncogene proteins, fusion - genetics (2) 2
pazopanib (2) 2
pbrm1 (2) 2
pediatric neuro-oncology (2) 2
precision medicine (2) 2
proto-oncogene proteins c-met - genetics (2) 2
receptor protein-tyrosine kinases - genetics (2) 2
renal cell carcinoma (2) 2
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer Research, ISSN 0008-5472, 07/2017, Volume 77, Issue 13 Supplement, pp. 398 - 398
Journal Article
Cancer Research, ISSN 0008-5472, 07/2016, Volume 76, Issue 14 Supplement, pp. 2629 - 2629
INTRODUCTION 
Journal Article
Cancer Discovery, ISSN 2159-8274, 08/2015, Volume 5, Issue 8, pp. 850 - 860
Journal Article
Journal Article
JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 10/2017, Volume 35, Issue 30, pp. 3391 - 3391
Journal Article
Journal Article
Pigment Cell & Melanoma Research, ISSN 1755-1471, 05/2018, Volume 31, Issue 3, pp. 432 - 436
BRAF and MEK inhibitors have improved clinical outcomes in advanced, BRAF V 600 ‐mutated melanomas. Acquired resistance occurs in most patients, with numerous... 
internal deletion | trametinib | vemurafenib | BRAF | dabrafenib | rearrangement | resistance | SURVIVAL | ACQUIRED-RESISTANCE | SENSITIVITY | MECHANISMS | MEK INHIBITORS | CELL BIOLOGY | DERMATOLOGY | METASTATIC MELANOMA | ONCOLOGY | Gene mutations | Melanoma | Alternative splicing | Signaling | Clonal deletion | Exons | MEK inhibitors | Extracellular signal-regulated kinase | Deletion | Raf protein | Pretreatment | Mutation | Gene deletion
Journal Article
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 06/2019
Presently, PD-L1 is the most commonly used biomarker to predict response to immune checkpoint inhibitors (ICIs) in non-small cell lung cancer (NSCLC). Owing to... 
Journal Article
Journal Article
Journal Article
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.